pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Jul 7·1 min read
save

Tampa General Hospital sues Eli Lilly over 340B discount halt

Jul 7, 2026·read at Endpoints ↗RegulatoryNegative

Tampa General Hospital filed a lawsuit against Eli Lilly, alleging the drugmaker stopped providing 340B program discounts to the hospital.

The dispute centers on Lilly's new requirement that hospitals submit detailed claims data to continue receiving discounted prices, which Tampa General says is unlawful.

The case could set a precedent for how pharmaceutical companies can condition 340B discounts on data reporting, potentially affecting many hospitals and drug pricing arrangements.

The lawsuit was filed Thursday, and both parties have indicated they will vigorously defend their positions as the broader industry watches.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Tampa General kicks off legal fight over Lilly's 340B restrictions”

read at Endpoints ↗
81 words · retrieved Jul 8
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LILLY4ELI LILLY CO2

related stories

  • May 6Lilly plans new $4.5B manufacturing investment in IndianaEndpoints
  • May 6Cases and Conversations™: Next-Generation Pathology Advances and Considerations for Precision Care in Non–Small Cell Lung Canceronclive
  • May 6Novo hikes guidance on Wegovy pill’s fast sales startBioPharma Dive
  • May 6STAT+: Novo Nordisk’s less-bad news on its Wegovy pill boosts earnings and share priceSTAT
  • May 4STAT+: French regulator fines Novo and Lilly over weight loss ad campaignsSTAT